Vit E/ Selenite Inj Solution

Verify with FDA CVM →

121 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
121
Total Reports
45
Deaths Reported
3720.0%
Death Rate

Active Ingredients

Vit E/ Selenite Inj Solution

Administration Routes

SubcutaneousUnknownIntramuscularIntravenousParenteralOral

Species Affected

Cattle 65
Horse 27
Unknown 10
Goat 8
Human 4
Sheep 3
Alpaca 2
Other Deer 1
Dog 1

Most Affected Breeds

Holstein-Friesian also known as Holstein 24
Unknown 16
Cattle (other) 12
Aberdeen Angus 9
Quarter Horse 9
Thoroughbred 7
Red Angus 5
Crossbred Bovine/Cattle 4
Charolais 3
Sheep (unknown) 3

Most Reported Reactions

Death 39
Anaphylaxis 20
Lack of efficacy - NOS 14
Recumbency 8
Injection site swelling 8
Increased respiratory rate 6
Laboured breathing 6
Anaphylactic-type reaction 6
Death by euthanasia 6
Injection site abscess 5
Foaming at the mouth 5
Ataxia 5

Outcome Breakdown

Recovered/Normal
46 (34.8%)
Died
40 (30.3%)
Outcome Unknown
21 (15.9%)
Ongoing
18 (13.6%)
Euthanized
6 (4.5%)
Recovered with Sequela
1 (0.8%)

Data Summary

Metric Value
Total adverse event reports 121
Reports involving death 45
Case-fatality rate (reported events) 3720.0%
Distinct species in reports 9
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Vit E/ Selenite Inj Solution Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 121 adverse event reports referencing Vit E/ Selenite Inj Solution, including 45 reports in which the animal died — a 3720.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Vit E/ Selenite Inj Solution. Reported administration routes include Subcutaneous, Unknown, Intramuscular, Intravenous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Vit E/ Selenite Inj Solution reports are Cattle (65 reports), Horse (27 reports), Unknown (10 reports), with Cattle accounting for the largest share. Within those species, Holstein-Friesian also known as Holstein (24), Unknown (16), Cattle (other) (12) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Vit E/ Selenite Inj Solution are Death (39), Anaphylaxis (20), Lack of efficacy - NOS (14), Recumbency (8). Of the 132 reports with a coded outcome, Recovered/Normal is the leading category at 34.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Vit E/ Selenite Inj Solution.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial